Christian Schulz

Prof. Dr. Christian Schulz


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2002 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
PDF file
CSChristian Schulz
Christian Schulz
LFL. Farkas
L. Farkas
KWK. Wolf
K. Wolf
KKK. Krätzel
K. Krätzel
GEG. Eissner
G. Eissner
MPM. Pfeifer
M. Pfeifer
Lipopolysaccharide (LPS) as a major component of the outer membrane of gram‐negative bacteria stimulates various cells to initiate a signalling cascade which ultimately leads to cell activation and expression of immunoregulatory or inflammatory cytokines. The human respiratory epithelium is an important environmental interface, but differences in LPS‐induced cell activation between bronchial and alveolar epithelial cells have not yet been investigated in detail. First, the expression of Toll‐like receptors (TLRs), as pattern‐recognition receptors, was investigated for the bronchial epithelial cells and type II‐like pneumocytes, demonstrating that they fulfil the prerequisites for LPS signalling. Thereafter, the effects of LPS, soluble CD14 (sCD14) and LPS‐binding protein (LBP) on the release of interleukin‐6 (IL‐6) and IL‐8 were studied. In the presence of LPS, sCD14 induced a significant and concentration‐dependent cytokine release in type II‐like pneumocytes, whereas the response of bronchial epithelial cells to sCD14 stimulation was low, implicating sCD14‐independent activation mechanisms. Furthermore, LBP revealed inhibitory effects on the activation of alveolar epithelial cells, which may represent a novel local defence mechanism during gram‐negative infection. We conclude that distinct pathways exist for LPS‐induced activation of bronchial and alveolar epithelial cells.

1 June 2003 in Respiration
Verified
Journal Article
Closed access
CSChristian Schulz
Christian Schulz
KWKonrad Wolf
Konrad Wolf
MHMartina Harth
Martina Harth
KKKirsten Krätzel
Kirsten Krätzel
LKLeoni Kunz-Schughart
Leoni Kunz-Schughart
MPMichael Pfeifer
Michael Pfeifer
Background: One of the consistently observed features in chronic obstructive pulmonary disease (COPD) are markedly increased neutrophils in the airways which are accompanied by increased levels of interleukin-8 (IL-8) in induced sputum and bronchoalveolar lavage fluid. To some extent, IL-8 may derive from bronchial epithelial cells since airway epithelium plays a crucial role in initiating and augmenting host defense mechanisms. Objectives: We hypothesized that a marked increase in bronchoepithelial IL-8 expression and release may be found in the airway epithelium of COPD patients compared to ‘healthy’ smokers and never-smokers. Methods: Primary bronchoepithelial cell cultures from COPD patients, smokers, and never-smokers were established. The unstimulated and TNFα-induced IL-8 release was measured by enzyme-linked immunosorbent assay. In addition, mRNA expression levels were quantified by means of reverse transcriptase polymerase chain reaction and light cycler measurements. Results: In subjects with COPD the constitutive and stimulated IL-8 release was significantly higher compared to ‘healthy’ smokers and control subjects, whereas no differences were seen between smokers and the control group. Quantitative assessment of transcript levels confirmed these data, displaying significantly higher mRNA levels in primary bronchial epithelial cells from COPD patients compared to controls (p < 0.05) in uninduced and stimulated conditions (p < 0.05). Conclusions: These results suggest that patients with chronic obstructive airflow limitation are characterized by a significant upregulation of bronchial epithelial IL-8 expression levels and secretion, indicating specific differences in epithelial cell activation in COPD patients compared to smokers and control subjects.

23 February 2021 in Cancer Reports
Verified
Journal Article
Open access
PDF file
JKJulia Karnosky
Julia Karnosky
WDWolfgang Dietmaier
Wolfgang Dietmaier
HKHelge Knuettel
Helge Knuettel
VFViola Freigang
Viola Freigang
MKMyriam Koch
Myriam Koch
CSChristian Schulz
Christian Schulz
Background: Lung cancer has emerged as a global public health problem and is the most common cause of cancer deaths by absolute cases globally. Besides tobacco, smoke infectious diseases such as human papillomavirus (HPV) might be involved in the pathogenesis of lung cancer. However, data are inconsistent due to differences in study design and HPV detection methods.Aim: A systematic meta‐analysis was performed to examine the presence of HPV‐infection with lung cancer.Methods and Results: All studies in all languages were considered for the search concepts “lung cancer” and “HPV” if data specific to HPV prevalence in lung cancer tissue were given. This included Journal articles as well as abstracts and conference reports. As detection method, only HPV PCR results from fresh frozen and paraffin‐embedded tissue were included. Five bibliographic databases and three registers of clinical trials including MEDLINE, Embase, Cochrane Library, and ClinicalTrials.gov were searched through February 2020. A total 4298 publications were identified, and 78 publications were selected, resulting in 9385 included lung cancer patients. A meta‐analysis of 15 case‐control studies with n = 2504 patients showed a weighted overall prevalence difference of 22% (95% CI: 12%‐33%; P < .001) and a weighted overall 4.7‐fold (95% CI: 2.7‐8.4; P < .001) increase of HPV prevalence in lung cancer patients compared to controls. Overall, HPV prevalence amounted to 13.5% being highest in Asia (16.6%), followed by America (12.8%), and Europe (7.0%). A higher HPV prevalence was found in squamous cell carcinoma (17.9%) compared to adenocarcinoma (P < .01) with significant differences in geographic patterns. HPV genotypes 16 and 18 were the most prevalent high‐risk genotypes identified.Conclusion: In conclusion, our review provides convincing evidence that HPV infection increases the risk of developing lung cancer.

20 May 2022 in European Journal of Cancer
Verified
Journal Article
Closed access
PCPetros Christopoulos
Petros Christopoulos
KKKlaus Kluck
Klaus Kluck
MKMartina Kirchner
Martina Kirchner
HLHeike Lüders
Heike Lüders
JRJulia Roeper
Julia Roeper
MTMichael Thomas
Michael Thomas

1 May 2004 in Chest
Verified
Journal Article
Closed access
PDF file
CSChristian Schulz
Christian Schulz
KKKirsten Kra¨tzel
Kirsten Kra¨tzel
KWKonrad Wolf
Konrad Wolf
SSStephan Schroll
Stephan Schroll
MKMartina Köhler
Martina Köhler
MPMichael Pfeifer
Michael Pfeifer

1 September 2003 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
CSChristian Schulz
Christian Schulz
VPV. Petrig
V. Petrig
KWK. Wolf
K. Wolf
KKK. Krätzel
K. Krätzel
MKM. Köhler
M. Köhler
MPM. Pfeifer
M. Pfeifer
An increasing body of evidence indicates that the bronchial epithelium plays a crucial role in the pathophysiology of chronic obstructive pulmonary disease (COPD). The aim of this study was to identify new genes whose bronchoepithelial expression is specifically altered in COPD patients.Primary bronchial epithelial cell (PBEC) cultures were established from exsmokers with stable airflow limitation and never smokers. Complementary deoxyribonucleic acid array technology was used to investigate the differential expression of 847 cytokine and cytokine-related genes between the two groups. Statistical analysis was performed by means of significance analysis of microarrays and Bonferroni-corrected analysis of variance on ranks. Discriminant analysis and light cycler measurements as well as flow cytometry and Western blotting were used to confirm the significance of the array results at both the messenger ribonucleic acid (mRNA) and protein expression levels.With respect to array experiments, melanoma cell adhesion molecule (MCAM) was identified as the sole gene showing highly significant upregulation in PBECs from COPD patients compared to never smokers. Light cycler measurements confirmed these results, revealing a 2.9‐fold and 2.0‐fold increase in MCAM mRNA expression in COPD patients compared to nonsmokers and smokers, respectively. In addition, these differences are associated with higher median protein expression levels.These results strongly suggest involvement of melanoma cell adhesion molecule in the pathophysiology of the chronic airway inflammation seen in patients with chronic obstructive pulmonary disease.